US Patent Issued to Tempus AI on April 14 for "Calculating cell-type RNA profiles for diagnosis and treatment" (Illinois Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,603,150, issued on April 14, was assigned to Tempus AI Inc. (Chicago).

"Calculating cell-type RNA profiles for diagnosis and treatment" was invented by Mathew Barber (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for determining a cancer composition of a subject are provided that include generating machine-learning models configured to identify cell types based on respective cell-type RNA expression profiles, and using the models to determine the cancer composition of the subject."

The patent was filed on Oct. 20, 2020, under Application No. 17/074,984.

*For further information, including images, charts and tables, please visit: http...